ArticleScientific reports2025
Potential utility of the triglyceride-glucose index as a predictor of erectile dysfunction and its severity: a cross-sectional, case-control study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this case-control study was to evaluate the relationship between triglyceride-glucose index (TyG Index) and erectile dysfunction (ED) and its severity. A total of 230 male patients, aged between 18 and 75 years, admitted to the urology outpatient clinic with complaining erectile dysfunction were evaluated. Routine blood serum tests performed to determine the etiology of ED were analyzed. TyG index was calculated. All patients were requested to fill in the validated Turkish version of the 5-item International Index of erectile function (IIEF-5) survey. ED severity of patients was determined according to IIEF-5 scores and data of patients with and without ED were compared. The ED group exhibited higher values for body mass index, waist circumference, fasting blood glucose, ALT, and triglycerides compared to the control group (p < 0.05). In contrast, AST and total testosterone levels were significantly lower in the ED group (p < 0.05). The TyG index was significantly higher, and IIEF scores were lower in the ED group (p < 0.05). Moreover, the TyG index was elevated across all ED subgroups (severe, moderate, mild-moderate, and mild) compared to the control group (p < 0.05). The TyG index demonstrated significant effectiveness in distinguishing severe ED from all other ED groups. Based on the results of our study, the TyG index appears to be a simple method that shows a high correlation with the severity of ED. We believe that the use of the TyG index in the diagnosis and follow-up of ED is noteworthy, and further prospective studies with larger sample sizes are needed to support this conclusion.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.